Inventor · disambiguated record
Edward Yin-Shiang Lin
Also filed as: LIN EDWARD · LIN EDWARD Y · LIN EDWARD YIN-SHIANG
31 granted patents·25 pending applications·173 citations·filing 2004–2024
96Inventor score
Files withBIOGEN MA INC34BIOGEN IDEC INC6SUNESIS PHARMACEUTICALS INC5Caldwell richard d2THOMAS JERMAINE2
Top patents by PatentIndex Score
56 records- 0192US10166250B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Jan 1, 2019·9 cites·11 claims
- 0292US9572824B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Feb 21, 2017·10 cites·14 claims
- 0392US8802659B2Bicyclic aryl sphingosine 1-phosphate analogsTHOMAS JERMAINE·Filed 2010·Granted Aug 12, 2014·20 cites·24 claims
- 0491US9827258B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Nov 28, 2017·8 cites·10 claims
- 0591US9186367B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2014·Granted Nov 17, 2015·15 cites·14 claims
- 0691US8293923B2Indazole derivatives as modulators of interleukin-1 receptor-associated kinaseGUCKIAN KEVIN·Filed 2007·Granted Oct 23, 2012·52 cites·27 claims
- 0789US8778977B2Pyridinonyl PDK1 inhibitorsLIND KENNETH EGNARD·Filed 2007·Granted Jul 15, 2014·21 cites·15 claims
- 0884US9850206B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 26, 2017·4 cites·22 claims
- 0984US9340527B2S1P modulating agentsTHOMAS JERMAINE·Filed 2012·Granted May 17, 2016·6 cites·38 claims
- 1084US9181191B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2012·Granted Nov 10, 2015·3 cites·38 claims
- 1184US2024294524A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1282US8349849B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2009·Granted Jan 8, 2013·6 cites·21 claims
- 1381US10034869B2S1P modulating agentsBIOGEN MA INC·Filed 2017·Granted Jul 31, 2018·2 cites·18 claims
- 1480US12275728B2O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitorsBIOGEN MA INC·Filed 2024·Granted Apr 15, 2025·0 cites·2 claims
- 1580US10030016B2Heterocyclic compounds useful as PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 24, 2018·2 cites·16 claims
- 1680US9808449B2S1P modulating agentsBIOGEN MA INC·Filed 2015·Granted Nov 7, 2017·2 cites·21 claims
- 1777US8546359B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2012·Granted Oct 1, 2013·4 cites·31 claims
- 1877US2023113598A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1976US10894040B2S1P modulating agentsBIOGEN MA INC·Filed 2019·Granted Jan 19, 2021·0 cites·20 claims
- 2074US8269043B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2009·Granted Sep 18, 2012·2 cites·19 claims
- 2174US2024279197A1Nrf2 activatorBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 2270US9546165B2Heterocyclic compounds useful as PDK1 inhibitorsARNDT JOSEPH·Filed 2010·Granted Jan 17, 2017·2 cites·12 claims
- 2370US2021070752A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2466US8017733B2Polyalkylene polymer compounds and uses thereofBIOGEN IDEC INC·Filed 2004·Granted Sep 13, 2011·4 cites·6 claims
- 2566US2019209592A1Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 2665US10406144B2SIP modulating agentsBIOGEN MA INC·Filed 2018·Granted Sep 10, 2019·0 cites·18 claims
- 2763US2021387960A1Nrf2 activatorBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 2863US2019119268A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2962US9873693B2Methods of treatment using pyridinonyl PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2014·Granted Jan 23, 2018·0 cites·15 claims
- 3061US2022048884A1Nrf2 activatorBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 3160US10081646B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·0 cites·26 claims
- 3260US2025152574A1Emopamil-binding protein inhibitors and uses thereofBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 3360US2025171463A1Emopamil-binding protein inhibitors and uses thereofBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 3460US2018370966A1Methods of treatment using pyridinonyl pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3560US2025161281A1Emopamil-binding protein inhibitors and uses thereofBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 3660US2025304577A1Tyk2 inhibitorsBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 3759US8524660B2Polyalkylene polymer compounds and uses thereofLIN KOCHUNG·Filed 2011·Granted Sep 3, 2013·1 cites·3 claims
- 3858US2021340107A1Nrf2 activatorBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 3957US12180205B2O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitorsBIOGEN MA INC·Filed 2019·Granted Dec 31, 2024·0 cites·20 claims
- 4057US2023117898A1O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 4157US2025090524A1Btk inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 4255US9708353B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Jul 18, 2017·0 cites·29 claims
- 4355US2015246097A9Polyalkylene Polymer Compounds and Uses ThereofBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 4455US2019389830A1Nrf2 activatorBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 4552US10968181B2NRF2 activatorBIOGEN MA INC·Filed 2017·Granted Apr 6, 2021·0 cites·24 claims
- 4652US2019389836A1Nrf2 activatorBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 4752US2024083900A1Pyrazolo[1,5-a]pyrazine derivatives as btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 4852US2024327380A1Btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 4950US12421224B2Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitorsBIOGEN MA INC·Filed 2020·Granted Sep 23, 2025·0 cites·20 claims
- 5049US2010035918A1Imidazolone Compounds and Methods of Making and Using the SameBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →